Results for: glaxosmithkline

Tasmanian Primary Industries Minister doesn't rule out lifting ban on...

Swiss agency approves trial for Ebola vaccine

Novartis Third-Quarter Profit Rises on Sales of New Medicines

Regus forecasts capex below estimates, eases fears over debt

Sanofi shares sink as diabetes sales slow, CEO pressured

Novartis results top forecasts as new products gain momentum

Mali seeks to contain Ebola fears after girl dies

Mali residents panic after first Ebola death

Drugmakers bet on Ebola vaccines, treatments

Sanofi’s Chief Said Facing Pressure From Some Board Members

WHO eyes mass Ebola vaccines by mid-2015

GSK cancer drug combination gets U.S. priority review

China arrests British, American investigators

Chinese crystal meth makers 'used GSK cold medicine'

One dose of HPV vaccine may prevent cervical cancer

South Africa winning malaria fight with DDT help: report

UK's GlaxoSmithKline aims to market first malaria vaccine

GSK distances itself from employees in China probe

Japan's top drugmaker appoints first foreign boss

Cameron heads to China aiming to end Dalai Lama row

GSK recalls kids Panadol

India announces low-cost rotavirus vaccine

GSK in $350 million deal to develop cancer drugs with UK biotech firm

New drugs may make a dent in lung, ovarian cancer

GSK open to selling healthcare business

Sex video new twist in GSK China bribery scandal

Sex video is new twist in GSK China bribery scandal

Japan drugmaker Takeda says will fight $6.0 bn US damages order

Chinese police to brief media on GlaxoSmithKline on Wednesday amid probe

Study shows Glaxo heart drug which failed trial has potential benefit

Race on for Ebola drug

Ebola vaccine trials being fast-tracked: researchers

Nigeria monitoring 400 contacts of doctor who died of Ebola